Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Antibody Production and Purification
  5. General Antibody Purification Products
  6. Novex™ Protein A - Sepharose™ 4B 

Novex™ Protein A - Sepharose™ 4B

Catalog No. 101041
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mL
25 mL
1 L
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
10-104-1 5 mL
10-104-2 25 mL
10-109-0 1 L
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
Catalog No. 10-104-1 Supplier Novex™ Supplier No. 101041
Only null left
Add to Cart
Add to Cart

Description

Protein A - Sepharose™ 4B

This product is prepared by covalently coupling highly purified (>98% by SDS-PAGE) Staph. aureus Cowan strain 1 Protein A to Sepharose™ 4B.

This product is supplied as a 50% suspension consisting of Protein A-Sepharose™ 4B and PBS (10 mM phosphate-buffered saline, pH 7.4, containing 0.1% Proclin).

Applications: Immunoglobulin Affinity Purification, Immunoprecipitation
TRUSTED_SUSTAINABILITY

Specifications

Product Type Protein A Sepharose
Product Line Sepharose
Column Type Affinity
Stationary Phase Protein A
Content And Storage This product is supplied as a 50% suspension (5 ml Protein A-Sepharose™ 4B + 5 ml PBS) Wet Ice
Quantity 5 mL
Form Suspension

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov

For Research Use Only. Not for use in diagnostic procedures.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.